Concepedia

Camille Chakiba-Brugère

CC

Statistics

Publications

3

Citations

473

H-Index

3

Active since

2019

Affiliations

Institut Bergonié(Current)

Frontier Agriculture (United Kingdom)

University of Pittsburgh

Seoul National University Hospital

King's College London

Camille Chakiba-Brugère is an author at Institut Bergonié specializing in oncology, malignant neoplasms, and medicine.

Publications per year

2019–2024

3

Publications

3

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Adenosquamous Carcinoma of the Pancreas

Hélène Del Arco, Camille Chakiba-Brugère, Laura Salabert et al. · Clinical Medicine Insights Oncology · 2019 · 15 citations · Full text

Medicine, Oncology, Surgery +10

Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g<i>BRCA1/2</i> Mutations and High-Risk Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer

Patricia A. Ganz, Hanna Bandos, Tanja Španić et al. · Journal of Clinical Oncology · 2024 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17

1–3 of 3